Proteome Sciences has a strong track record in biomarker discovery, innovation and intellectual property. PS is a life sciences company delivering content for personalized medicine in the areas of Biomarker Services, Biomarker Assays, Isobaric and Isotopic Reagents and Proprietary Biomarkers
PS, a global leader in applied proteomics, uses high sensitivity proprietary technologies to detect biomarkers (differentially expressed proteins in diseases) and to develop rapid assays for testing. The biomarkers discovered in body fluids or tissues are validated, developed and commercialized as diagnostic, prognostic or therapeutic products through strategic alliances and out-licensing.
A detailed list of assays can be found in the ‘Products and Services' section. Learn More..
A modular biomarker outsourcing solution to the pharmaceutical, biotechnology and diagnostics industries
Separate modules for discovery, validation and routine measurement of biomarkers are based around proprietary isobaric and isotopic Tandem Mass Tags® (TMT®) and both gel-based and gel-free separation technologies linked to state-of-the-art mass spectrometry. This significantly increases the speed, robustness and precision of biomarker discovery/quantification and facilitates the rapid transition to multiplex biomarker assays for routine application using mass spectrometry (TMT®-SRM assays). Learn More..
A broad selection of proprietary protein biomarkers across a range of key human diseases
Proteome Sciences has established a comprehensive intellectual property portfolio covering markers in CNS disorders (Alzheimer’s, stroke, traumatic brain injury, TSE’s & pain), Oncology (lung, breast, esophageal, colorectal cancers & neuroblastoma) and organ transplant rejection (renal, cardiac). Learn More..
Proteome Sciences’ patented isobaric mass tag technology
Proteome Sciences has developed a range of novel isobaric and isotopic reagents under the Tandem Mass Tag® brand which are licensed and distributed worldwide by Thermo Scientific. TMT® works like a car tracker system to uniquely tag proteins and peptides, radically reducing the variability of biomarker discovery and speeding up the transition to biomarker validation. Proteome Sciences controls the global isobaric mass tag space through issued US and European TMT® patents. Learn More..
We develop and implement measurably better tools for the discovery, validation and implementation of protein and peptide biomarkers across a range of major human diseases where there are substantial and significant unmet needs. We enable our partners to succeed in the delivery of more effective healthcare through the provision of high quality biomarkers and assays together with rapid, cost effective outsourcing services.